GenScript Biotech Reports Robust Growth in 2024
GenScript Biotech sees 43.5% revenue rise, expanding global reach and strengthening pipeline.
- Latest
- Trending
GenScript Biotech sees 43.5% revenue rise, expanding global reach and strengthening pipeline.
Precision fermentation is a pioneering biotech process for creating bio-based materials. Danone plans to debut demo-scale production by 2025, expanding ...
A groundbreaking technique combining CRISPR gene editing and nanopore sensing could speed up pathogen detection. This major advancement in infectious ...
Codexis partners with Innovatus for a $40 million loan to revolutionize RNAi therapeutic production, advancing their ECO Synthesis™ platform for ...
Otsuka's phase 3 trial for AVP-786 in treating agitation in Alzheimer's patients has failed to meet the primary efficacy endpoint. ...
Invizyne Technologies files registration statement with SEC for public offering. Offering consists of 4.3 million shares priced at $4.00 per ...
Novo Nordisk sees massive sales jump and expects further growth in 2024, driven by the demand for its diabetes and ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.